STOCK TITAN

Ambarella, Inc. Announces First Quarter Fiscal Year 2027 Financial Results

(Neutral)
Tags

Ambarella (NASDAQ: AMBA) reported Q1 FY2027 revenue of $100.4 million, up 16.9% year over year. GAAP gross margin was 58.4% and non-GAAP 59.9%.

GAAP net loss was $18.1 million (−$0.41 per share), while non-GAAP net income was $5.0 million ($0.11 per share). Q2 FY2027 guidance targets revenue of $105–$111 million. Cash and investments were $277.8 million. The board also authorized a new $50 million share repurchase program and the company bought 47,798 shares for $2.4 million in Q1.

Loading...
Loading translation...

Positive

  • Q1 FY2027 revenue $100.4M, up 16.9% year over year
  • Q1 GAAP net loss improved to $18.1M from $24.3M year over year
  • Q1 non-GAAP net income $5.0M vs. $3.0M a year earlier
  • Q2 FY2027 revenue guidance of $105–$111M
  • Q1 cash, equivalents and marketable securities $277.8M vs. $259.4M a year ago
  • New $50.0M share repurchase authorization through June 30, 2027
  • Q1 repurchase of 47,798 shares for approximately $2.4M

Negative

  • Q1 GAAP net loss of $18.1M (−$0.41 per diluted share)
  • Q1 GAAP gross margin fell to 58.4% from 60.0% year over year
  • Q1 non-GAAP gross margin declined to 59.9% from 62.0% year over year
  • Cash, equivalents and marketable securities $277.8M vs. $312.6M in prior quarter

News Market Reaction – AMBA

-21.41% 5.3x vol
78 alerts
-21.41% Session close to close
+2.3% Peak Tracked
-17.4% Trough Tracked
$4.03B Market Cap
5.3x Rel. Volume

In the May 29 session, AMBA declined 21.41%, reflecting a significant negative market reaction. Argus tracked a peak move of +2.3% during that session. Argus tracked a trough of -17.4% from its starting point during tracking. Our momentum scanner triggered 78 alerts that day, indicating high trading interest and price volatility. Trading volume was exceptionally heavy at 5.3x the daily average, suggesting significant selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -21.4% in the session following this news. A negative reaction despite revenue gro...
Analysis

The stock dropped -21.4% in the session following this news. A negative reaction despite revenue growth and non‑GAAP profitability fits the historical pattern, with prior earnings averaging a -9.82% move. Pressure on GAAP and non‑GAAP margins and continued GAAP net losses may reinforce caution. If selling extended beyond past norms, it could signal increasing concern about sustainability of growth, cash usage trends, or the pace at which edge AI investments translate into durable profitability.

Key Figures

Q1 FY2027 revenue: $100.4M Q1 FY2027 GAAP gross margin: 58.4% Q1 FY2027 GAAP net loss: $18.1M ($0.41/share) +5 more
8 metrics
Q1 FY2027 revenue $100.4M Quarter ended April 30, 2026; up 16.9% vs $85.9M in Q1 FY2026
Q1 FY2027 GAAP gross margin 58.4% Versus 60.0% in the same quarter FY2026
Q1 FY2027 GAAP net loss $18.1M ($0.41/share) Improved from $24.3M loss ($0.58/share) in Q1 FY2026
Q1 FY2027 non-GAAP net profit $5.0M ($0.11/share) Up from $3.0M ($0.07/share) in Q1 FY2026
Q2 FY2027 revenue guidance $105.0M–$111.0M Management outlook for quarter ending July 31, 2026
Q2 non-GAAP gross margin guide 59.0%–60.5% Expected non-GAAP gross margin for Q2 FY2027
Cash & securities $277.8M End of Q1 FY2027 vs $312.6M prior quarter and $259.4M year-ago
Share repurchase 47,798 shares; ~$2.4M; $50.0M new program Q1 FY2027 buybacks and new authorization through June 30, 2027

Previous Earnings Reports

5 past events · Latest: Feb 26 (Positive)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Feb 26 Q4/FY26 earnings Positive -14.9% Q4 and FY2026 revenue growth with non-GAAP profitability and FY2027 guidance.
Nov 25 Q3 FY26 earnings Positive -18.8% Q3 FY2026 revenue up 31.2% with positive non-GAAP earnings and Q4 guidance.
Aug 28 Q2 FY26 earnings Positive +16.8% Q2 FY2026 revenue up 49.9% and return to non-GAAP profitability with raised outlook.
May 29 Q1 FY26 earnings Positive -15.1% Q1 FY2026 revenue growth, first AI records, and higher FY2026 guidance.
Feb 26 Q4/FY25 earnings Positive -17.1% Q4 and FY2025 double‑digit revenue growth and strong edge AI contribution.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings releases have often been followed by negative price reactions, even when revenue growth and non-GAAP profitability metrics were strong.

Recent Company History

Over the past year, Ambarella’s earnings reports have highlighted strong revenue growth and increasing edge AI exposure, yet the stock frequently sold off afterward. Prior earnings on Feb 26, 2026, Nov 25, 2025, May 29, 2025, and Feb 26, 2025 all showed solid top-line growth and improving non‑GAAP profitability but produced next‑day moves of -14.89%, -18.78%, -15.1%, and -17.13%. The current Q1 FY2027 report continues the pattern of revenue growth and non‑GAAP profits against a cautious market response.

Key Terms

gaap, non-gaap, stock-based compensation, acquisition-related costs, +3 more
7 terms
gaap financial
"Gross margin under U.S. generally accepted accounting principles (GAAP) for the first..."
GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.
View in glossary
non-gaap financial
"Financial results on a non-GAAP basis for the first quarter of fiscal 2027 are as follows..."
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
View in glossary
stock-based compensation financial
"Non-GAAP financial information excludes the impact of stock-based compensation and..."
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
View in glossary
edge ai technical
"Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced..."
Edge AI refers to artificial intelligence systems that process data directly on local devices or nearby servers rather than sending information to distant data centers. This allows for faster decision-making and real-time responses, similar to how a home security camera can instantly detect motion without needing to connect to a remote server. For investors, edge AI represents a growing trend toward more efficient, responsive technology that can create new opportunities across various industries.
asp financial
"all of which command average selling prices (“ASP”) well in-excess of our current ASP."
Average selling price (ASP) is the typical price a company receives for a single unit of a product or service, calculated by dividing total revenue by units sold. Investors watch ASP because it shows whether a company is successfully charging more or less for its offerings — like checking the average price per loaf of bread a bakery sells — which directly affects revenue, profit margins, and the health of future sales.
soc technical
"Our edge SoCs integrate all the AI accelerated computing functions (perception, fusion..."
Standard of care (often abbreviated SOC) is the treatment or management approach that is widely accepted and used by medical professionals for a particular disease or condition. For investors, SOC provides the benchmark against which new therapies, devices, or clinical results are judged—like comparing a new car to the current most popular model; a product that meaningfully outperforms the SOC can win market share and drive revenue, while failure to beat or match it limits commercial potential.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SANTA CLARA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced first quarter fiscal 2027 financial results for the period ended April 30, 2026.

  • Revenue for the first quarter of fiscal 2027 was $100.4 million, up 16.9% from $85.9 million in the same period in fiscal 2026.
  • Gross margin under U.S. generally accepted accounting principles (GAAP) for the first quarter of fiscal 2027 was 58.4%, compared with 60.0% for the same period in fiscal 2026.
  • GAAP net loss for the first quarter of fiscal 2027 was $18.1 million, or loss per diluted ordinary share of $0.41, compared with a GAAP net loss of $24.3 million, or loss per diluted ordinary share of $0.58, for the same period in fiscal 2026.

Financial results on a non-GAAP basis for the first quarter of fiscal 2027 are as follows:

  • Gross margin on a non-GAAP basis for the first quarter of fiscal 2027 was 59.9%, compared with 62.0% for the same period in fiscal 2026.
  • Non-GAAP net profit for the first quarter of fiscal 2027 was $5.0 million, or earnings per diluted ordinary share of $0.11. This compares with non-GAAP net profit of $3.0 million, or earnings per diluted ordinary share of $0.07, for the same period in fiscal 2026.

Based on information available as of today, Ambarella is offering the following guidance for the second quarter of fiscal year 2027, ending July 31, 2026:

  • Revenue is expected to be between $105.0 million and $111.0 million.
  • Gross margin on a non-GAAP basis is expected to be between 59.0% and 60.5%.
  • Non-GAAP operating expenses are expected to be between $56.0 million and $59.0 million.

Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the impact of stock-based compensation and acquisition-related costs adjusted for the associated tax impact, which includes the effect of any benefits or shortfalls recognized. A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings (losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable debt securities on hand at the end of the first quarter of fiscal 2027 was $277.8 million, compared with $312.6 million at the end of the prior quarter and $259.4 million at the end of the same quarter a year ago.

“In Q1 we delivered on our key financial guidance while extending our edge AI platform leadership. Automotive revenue achieved a new all-time record due to rapid penetration of AI into commercial vehicles. Demand signals for edge AI remain very strong, and I am optimistic in our ability to serve the market, in particular as AI workloads become more complex. We have a number of new products targeting more advanced AI workloads, all of which command average selling prices (“ASP”) well in-excess of our current ASP.” said Fermi Wang, President & CEO.

“Our edge SoCs integrate all the AI accelerated computing functions (perception, fusion, AI accelerator, CPU and other system functions) together with our algorithms and software into a single SoC,” Dr. Wang added. “Customers are increasingly recognizing our unique capabilities and are requesting broader and deeper relationships, facilitating our development of new markets like edge infrastructure and robotics, while an indirect sales ecosystem can bring us more scale.”     

Stock Repurchase

In the first quarter of fiscal year 2027, the company repurchased a total of 47,798 shares for total consideration of approximately $2.4 million. During the second fiscal quarter, Ambarella’s Board of Directors authorized a new $50.0 million repurchase program through June 30, 2027, that will commence when the existing program expires on June 30, 2026. The repurchase program does not obligate the company to acquire any particular amount of ordinary shares, and it may be suspended at any time at the company’s discretion.

Quarterly Conference Call

Ambarella plans to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and John Young, Chief Financial Officer, to discuss the first quarter of fiscal year 2027 results. A live and archived webcast of the call will be available on Ambarella’s website at http://www.ambarella.com/ for up to 30 days after the call.

About Ambarella

With an installed base of more than 46 million AI SoC units, Ambarella’s products are utilized in a wide variety of physical edge AI applications, spanning edge endpoint and edge infrastructure use cases including physical security, vehicle safety, telematics, autonomy, portable video, aerial drones, and other emerging robotic applications. Building on this footprint, Ambarella offers a full-stack edge AI platform, from highly optimized silicon and programmable software to AI agentic frameworks that coordinate perception, decision-making and control across devices. Ambarella’s low-power systems-on-chip (SoCs) integrate proprietary and highly efficient perception and deep learning neural network AI accelerators, enabling electronic systems to become more productive with partial or complete levels of machine autonomy.  For more information, please visit www.ambarella.com.

"Safe harbor" statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,” “projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” “should,” or similar expressions, including the guidance for the second quarter of fiscal year 2027 ending July 31, 2026, and the comments of our CEO relating to demand for edge AI solutions, our ability to serve the edge AI market as it evolves, our ability to command higher prices for our new products, our ability to establish deeper relationships with our customers, our ability to further penetrate the edge infrastructure and robotics markets, and our ability to successfully build an indirect sales channel. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, global economic and political conditions; changes in government policies, including possible trade tariffs and restrictions; revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; our customers’ ability to manage their inventory requirements; our growth strategy; our ability to anticipate future market demands and future needs of our customers, particularly for AI inference applications; our ability to introduce, and to generate revenue from, new and enhanced solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as AI functionality and advanced networks, including vision-language models and GenAI; our ability to retain and expand customer relationships and to achieve design wins; the expansion of our current markets and our ability to successfully enter new markets and applications, such as edge infrastructure; anticipated trends and challenges, including competition, in the markets in which we operate; risks associated with global health conditions and associated risk mitigation measures; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form 10-K for our 2026 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also set forth in the company’s quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC's web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Quarterly Report on Form 10-Q for the first quarter of fiscal 2027 ended April 30, 2026 could differ from the preliminary results announced in this press release.

Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.

Non-GAAP Financial Measures

The company has provided in this release non-GAAP financial information, including non-GAAP gross margin, net income (loss), and earnings (losses) per share, as a supplement to the condensed consolidated financial statements, which are prepared in accordance with generally accepted accounting principles ("GAAP"). Management uses these non-GAAP financial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non-GAAP results are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from non-GAAP measures used by other companies.

With respect to its financial results for the first quarter of fiscal year 2027, the company has provided below reconciliations of its non-GAAP financial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the second quarter of fiscal year 2027, a reconciliation of non-GAAP gross margin and non-GAAP operating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAP measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.

AMBARELLA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
     
  Three Months Ended April 30,
   2026   2025 
   
Revenue $100,357  $85,872 
     
Cost of revenue  41,768   34,336 
Gross profit  58,589   51,536 
     
Operating expenses:    
Research and development  58,140   58,819 
Selling, general and administrative  19,865   18,575 
     
Total operating expenses  78,005   77,394 
     
Loss from operations  (19,416)  (25,858)
     
Other income, net  2,083   2,175 
     
Loss before income taxes  (17,333)  (23,683)
     
Provision for income taxes  760   645 
     
Net loss $(18,093) $(24,328)
     
Net loss per share attributable to ordinary shareholders:   
Basic $(0.41) $(0.58)
Diluted $(0.41) $(0.58)
Weighted-average shares used to compute net loss per share   
attributable to ordinary shareholders:    
Basic  43,605,282   42,219,972 
Diluted  43,605,282   42,219,972 
     


The following tables present details of stock-based compensation and acquisition-related costs included in each functional line item in the condensed consolidated statements of operations above:

 Three Months Ended April 30,
  2026  2025
 (unaudited, in thousands)
Stock-based compensation:   
Cost of revenue$783 $951
Research and development 13,714  17,585
Selling, general and administrative 7,396  7,594
    
Total stock-based compensation$21,893 $26,130
    


 Three Months Ended April 30,
  2026  2025
 (unaudited, in thousands)
Acquisition-related costs:   
Cost of revenue$757 $757
Research and development   
Selling, general and administrative 456  456
    
Total acquisition-related costs$1,213 $1,213
    


The difference between GAAP and non-GAAP gross margin was 1.5% and 2.0%, or $1.5 million and $1.7 million, for the three months ended April 30, 2026 and 2025, respectively. The differences were due to the effect of stock-based compensation and amortization of acquisition-related costs.

AMBARELLA, INC.
RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS (LOSSES) PER SHARE
(in thousands, except share and per share data)
    
 Three Months Ended April 30,
  2026   2025 
 (unaudited)
GAAP net loss$(18,093) $(24,328)
    
Non-GAAP adjustments:   
Stock-based compensation expense 21,893   26,130 
Acquisition-related costs 1,213   1,213 
Income tax effect 20   14 
Non-GAAP net income$5,033  $3,029 
    
GAAP - diluted weighted average shares 43,605,282   42,219,972 
Non-GAAP - diluted weighted average shares 43,899,823   42,451,235 
    
GAAP - diluted net loss per share$(0.41) $(0.58)
Non-GAAP adjustments:   
Stock-based compensation expense 0.50   0.62 
Acquisition-related costs 0.03   0.03 
Income tax effect     
Effect of Non-GAAP - diluted weighted average shares (0.01)   
Non-GAAP - diluted net income per share$0.11  $0.07 
    


AMBARELLA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands)
    
 April 30, January 31,
  2026   2026 
    
ASSETS   
Current assets:   
Cash and cash equivalents$114,443  $191,019 
Marketable debt securities 163,357   121,552 
Accounts receivable, net 39,175   39,180 
Inventories 80,355   52,246 
Restricted cash 442   442 
Prepaid expenses and other current assets 7,417   5,836 
Total current assets 405,189   410,275 
    
Property and equipment, net 12,594   11,553 
Intangible assets, net 59,024   58,046 
Operating lease right-of-use assets, net 11,510   12,118 
Goodwill 303,625   303,625 
Other non-current assets 2,896   2,983 
    
Total assets$794,838  $798,600 
    
LIABILITIES AND SHAREHOLDERS' EQUITY   
Current liabilities:   
Accounts payable 53,278   54,029 
Accrued and other current liabilities 92,519   97,964 
Operating lease liabilities, current 2,359   2,027 
Income taxes payable 1,768   1,531 
Deferred revenue, current 17,036   22,393 
Total current liabilities 166,960   177,944 
    
Operating lease liabilities, non-current 10,912   11,408 
Other long-term liabilities 11,148   14,459 
    
Total liabilities 189,020   203,811 
    
Shareholders' equity:   
Preference shares     
Ordinary shares 20   19 
Additional paid-in capital 951,980   922,119 
Accumulated other comprehensive income (loss) (167)  573 
Accumulated deficit (346,015)  (327,922)
Total shareholders’ equity 605,818   594,789 
    
Total liabilities and shareholders' equity$794,838  $798,600 
    



Contact:

Louis Gerhardy
408.636.2310
lgerhardy@ambarella.com






FAQ

How did Ambarella (AMBA) perform in Q1 fiscal 2027?

Ambarella reported Q1 FY2027 revenue of $100.4 million, up 16.9% year over year. According to Ambarella, GAAP net loss was $18.1 million (−$0.41 per share), while non-GAAP net income reached $5.0 million, or $0.11 per diluted share.

What Q2 fiscal 2027 guidance did Ambarella (NASDAQ: AMBA) provide?

Ambarella expects Q2 FY2027 revenue between $105.0 million and $111.0 million. According to Ambarella, non-GAAP gross margin is projected at 59.0%–60.5%, with non-GAAP operating expenses forecast between $56.0 million and $59.0 million for the quarter ending July 31, 2026.

What were Ambarella’s Q1 FY2027 gross margins on GAAP and non-GAAP bases?

For Q1 FY2027, Ambarella reported GAAP gross margin of 58.4% and non-GAAP gross margin of 59.9%. According to Ambarella, these compare with 60.0% GAAP and 62.0% non-GAAP gross margins in the same quarter of fiscal 2026, indicating lower margins year over year.

How did Ambarella’s cash and marketable securities change in Q1 FY2027?

Ambarella ended Q1 FY2027 with $277.8 million in cash, cash equivalents and marketable debt securities. According to Ambarella, this compares with $312.6 million at the prior quarter’s end and $259.4 million a year earlier, reflecting a sequential decline but year-over-year increase.

What share repurchase activity did Ambarella (AMBA) report for Q1 FY2027?

In Q1 FY2027, Ambarella repurchased 47,798 shares for approximately $2.4 million. According to Ambarella, its board also approved a new $50.0 million repurchase program running through June 30, 2027, which will begin after the current program expires on June 30, 2026.

What does Ambarella’s new $50 million buyback authorization mean for AMBA shareholders?

Ambarella’s board authorized a new $50.0 million share repurchase program through June 30, 2027. According to Ambarella, the program does not obligate any specific repurchase amount and can be suspended, but it provides flexibility to return capital by buying back ordinary shares.